Inventor
David S. Thomson
Inventor
Ridgefield, CT, US
Overview
Patents· 46 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations37%
C07DHeterocyclic compounds36%
C07CAcyclic or carbocyclic compounds10%
C04BLime, magnesia8%
A61KPreparations for medical, dental or toiletry purposes6%
C07BGeneral methods of organic chemistry2%
PatentTitleYear
8,829,034'Compounds which modulate the CB2 receptor'20148,741,897'Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof'20148,383,615'Azetidine 2-carboxamide derivatives which modulate the CB2 receptor'20138,362,039'Therapeutic uses of compounds which selectively modulate the CB2 receptor'20138,349,871'Therapeutic uses of compounds which selectively modulate the CB2 receptor'20138,299,111'Compounds which modulate the CB2 receptor'20128,268,859'Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof'20128,263,597'Indazole compounds as CCR1 receptor antagonists'20128,212,040'Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and thereof'20128,173,638'Compounds which modulate the CB2 receptor'20128,048,899'Compounds which selectively modulate the CB2 receptor'20118,008,327'Indazole compounds as CCR1 receptor antagonists'20117,935,715'Compounds which modulate the CB2 receptor'20117,932,392'Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof'20117,928,103'Compounds which modulate the CB2 receptor'20117,928,123'Compounds which modulate the CB2 receptor'20117,741,361'Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof'20107,635,711'Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof'20097,622,594'Glucocortioid mimetics, methods of making them, pharmaceutical compositions, and uses thereof'20097,595,397'Compounds which modulate the CB2 receptor'20097,579,469'Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof'20097,553,966'Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof'20097,279,472'Compounds useful as reversible inhibitors of cysteine proteases'20077,268,152'Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof'20077,265,132'Compounds useful as reversible inhibitors of cysteine proteases'20077,189,758'Glucocorticoid mimetics, methods of making them, pharmaceutical formulations, and uses thereof'20077,186,864'Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof'20077,074,806'Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof'20067,056,915'Compounds useful as reversible inhibitors of cysteine proteases'20066,982,263'Nitriles useful as reversible inhibitors of cysteine proteases'20066,982,272'Compounds useful as reversible inhibitors of cysteine proteases'20066,960,581'Glucocorticoid mimetics, methods of making them, pharmaceutical formulations, and uses thereof'20056,936,606'Cyanoamido-containing heterocyclic compounds useful as reversible inhibitors of cysteine proteases'20056,903,215'Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof'20056,858,623'Compounds useful as reversible inhibitors of cysteine proteases'20056,858,627'Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof'20056,787,540'Compounds useful as reversible inhibitors of cysteine proteases'20046,756,372'Compounds useful as reversible inhibitors of cysteine proteases'20046,730,671'Compounds useful as reversible inhibitors of cathespin S'20046,720,319'Compounds useful as reversible inhibitors of cysteine proteases'20046,649,642'Succinate derivative compounds useful as cysteine protease inhibitors'20036,608,057'Compounds useful as reversible inhibitors of cathepsin S'20036,525,052'Compounds useful as reversible inhibitors of cysteine proteases'20036,420,364'Compound useful as reversible inhibitors of cysteine proteases'20026,395,897'Nitrile compounds useful as reversible inhibitors of 9 cathepsin 5'20026,313,117'Succinate derivative compounds useful as cysteine protease inhibitors'2001Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2001–2014Patents assigned to BOEHRINGER INGELHEIM PHARMA (32)· patent assignee history
2001–2014Based in Ridgefield, CT, US· patent location history
2009–2013Patents assigned to BOEHRINGER INGELHEIM INT (13)· patent assignee history
2012–2014Patents assigned to RIETHER DORIS (8)· patent assignee history
2012–2014Patents assigned to HICKEY EUGENE RICHARD (6)· patent assignee history
2012–2014Patents assigned to BERRY ANGELA (5)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BOEHRINGER INGELHEIM PHARMA | 32 | 2001–2014 |
| BOEHRINGER INGELHEIM INT | 13 | 2009–2013 |
| RIETHER DORIS | 8 | 2012–2014 |
| HICKEY EUGENE RICHARD | 6 | 2012–2014 |
| BERRY ANGELA | 5 | 2012–2014 |
Locations
| Location | Patents | Span |
|---|---|---|
| Ridgefield, CT, US | 46 | 2001–2014 |